Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

HBsAg¾ç¼º °£ Áúȯ°ú HBsAgÀ½¼º °£ Áúȯ¿¡ À־ ÀϺΠÇ÷û È¿¼ÒÈ®Áõ¿¡ °üÇÑ ¿¬±¸ A Study on Serum Enzyme Activities in HBsAg Positive and HBsAg Negative Liver Diseases

´ëÇѺ´¸®ÇÐȸÁö 1982³â 16±Ç 2È£ p.157 ~ 164
±èÁ¤¹Ý, ÀÌÀº¿±, ±Ç¼øÈ£,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¤¹Ý (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óº´¸®Çб³½Ç

ÀÌÀº¿± (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óº´¸®Çб³½Ç
±Ç¼øÈ£ (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óº´¸®Çб³½Ç

Abstract

¿ä ¾à
ÀúÀÚµéÀº 1981³â 2¿ùºÎÅÍ µ¿³â 9¿ù »çÀÌ¿¡ ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ¼Óº´¿ø ³»°ú¸¦ ¹æ¹®ÇÏ
°Å³ª ¶Ç´Â ÀÔ¿øÇÑ È¯ÀÚ Áß ÀÓ»óÀûÀ¸·Î³ª ¶Ç´Â º´¸®Á¶Á÷ÇÐÀûÀ¸·Î È®ÁøµÈ ±Þ¼º°£¿° 23¿¹, ¸¸
¼º°£¿° 19¿¹, °£°æº¯Áõ 49¿¹, °£¼¼Æ÷¾Ï 27¿¹ ±×¸®°í °Ç°­´ëÁ¶±º 25¿¹¿¡¼­ Ç÷û AST, ALT,
AP ¹× r-GTPÀÇ È°¼ºµµ¸¦ ÃøÁ¤ÇÏ°í Ç÷û HBsAg¾ç¼º À¯¹«¿¡ µû¶ó HBsAg¾ç¼º °£Áúȯ±º°ú
HBsAg À½¼º °£Áúȯ±ºÀ¸·Î ³ª´©¾î¼­ ÀÌ ¾çÁúȯ±º »çÀÌ¿¡ ÀÌ È¿¼ÒµéÀÇ È²¼ºÀ» ¼­·Î ºñ±³ÇÏ
¿© ¾òÀº ¼ºÀûÀ» À§¿¡¼­ °í¾ÈÇÏ°í ´ÙÀ½°ú °°ÀÌ ¿ä¾àÇÏ¿´´Ù.
1) Ç÷û AST ¹× ALTÀÇ È°¼ºµµ´Â HBsAg¾ç¼º °£°æº¯Áõº¸´Ù HBsAgÀ½¼º °£°æº¯ÁõÀÌ ³ô
¾Ò´Ù.
2) Ç÷û r-GTP È°¼ºµµ´Â HBsAg À½¼º ¸¸¼º°£¿° ¹× °£°æº¯ÁõÀÌ HBsAg¾ç¼º ¸¸¼º°£¿° ¹×
°£°æº¯Áõ º¸´Ù ÀÇÀÇ ÀÖ°Ô ³ô¾Ò´Ù.
3) HBsAg¾ç¼º °£°æº¯Áõ¿¡¼­´Â Ç÷û AST¿Í APÈ°¼ºµµ »çÀÌ¿¡, ±×¸®°í ALT¿Í APÈ°¼ºµµ
»çÀÌ¿¡ °¢°¢ ÀÇÀÇ ÀÖ´Â ¾çÀÇ »óȯ°ü°è°¡ ÀÖ¾ú´Ù.
4) HBsAgÀ½¼º ±Þ¼º°£¿°¿¡¼­´Â ALT¿Í APÈ°¼ºµµ »çÀÌ¿¡ ±×¸®°í HBsAg¾ç¼º °£¼¼Æ÷¾Ï¿¡
¼­´Â Ç÷û AP¿Í r-GTP¶ô¼ºµµ »çÀÌ¿¡ °¢°¢ ¾çÀÇ »ó°ü°ü°è°¡ ÀÖ¾ú´Ù.
5) HBsAg¾ç¼º ¸¸¼º°£¿°¿¡ À־´Â Ç÷û ALT¿Í r-GTPÈ°¼ºµµ »çÀÌ¿¡ À½ÀÇ »ó°ü°ü°è°¡
ÀÖ¾ú´Ù.
ÀÌ»óÀÇ °á°ú¿¡ ÀÇÇÏ¿© HBsAg¾ç¼º °£ Áúȯ°ú À½¼º °£ ÁúȯÀ» °¨º°ÇÔ¿¡ À־ ÀϺΠÇ÷û
È¿¼ÒµéÀÇ ÃøÁ¤ÀÌ ´Ù¼Ò µµ¿òÀÌ µÉ °ÍÀ̶ó°í, »ý°¢µÈ´Ù.
#ÃÊ·Ï#
The authors investigated the activities of some serum enzymes in 66 casts of patients
with HBsAg Positive liver diseases and in 52 cases of patients with HBsAg negative
ones and 25 cases of adult healthy controls. The patients with HBsAg positive liver
diseases were consisted of 14 cases of acute hepatitis, 8 cases of chronic hepatitis, 25
casts o( liver cirrhosis and 15 cases of hepatocellular carcinoma. An4 the patients with
HBsAg negative live diseases comprised 9 cases of acute hepatitis, 11 cases of chronic
hepatitis, 20 cases of liver cirrhosis and 12 cases of hepatocellular carcinoma. Diagnosis
wag confirmed clinically and Pathologically in all the Patients. Serum HBsAg was
detected by reverse massive hemagglutination test. Serum aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) activities were measured by
Reitman-Frankel method. And serum alkaline phosphatase (AP) activity was estimated
by Kind-King method and serum gamma-glutamyl transpeptidase (r-GTP) activity by
Orlowski method,
The results obtained were summarized as follows :
1) The activities of serum AST and ALT were significantly higher in HBsAg positive
liver cirrhosis than those in HBsAg negative one.
2) The activity of serum r-GTP was significantly higher in HBsAg positive chronic
hepatitis and liver cirrhosis than that in HBsAg negative ones.
3) In HBsAg positive liver cirrhosis, a significant positive correlation was found
between AST and AP activity and between ALT and AP activity, in HBsAg negative
acute hepatitis between ALT and AP activity and in HBsAg positive hepatocellular
carcinoma between AP and r-GTP activity, respectively.
4) In the HBsAg positive chronic hepatitis, a significant negative correlation was also
observed between serum ALT and r-GTP activity.
On the basis of the result mentioned above, it is suggested that estimation of some
serum enzyme activities mar be somewhat helpful for differentiation between HBsAg
positive ana HBsAg negative liver diseases.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS